Penile Carcinoma, Squamous Cell Carcinoma of the Penis
Conditions
Brief summary
This study develops a prospective database of patients who are evaluated and treated for penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors, treatment, complications, and tumor progression. It will also prospectively validate the importance of pathological prognostic factors previously reported and outcome related to contemporary treatment.
Detailed description
PRIMARY OBJECTIVE: I. To prospectively collect data on the presenting features, management and outcome of penile carcinoma at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, The Woodlands and Bay Area Regional Care Centers. OUTLINE: Patients undergo data collection every 6 months for up to 15 years.
Interventions
OTHERData Capture
Data collected
OTHERQuestionnaire Administration
Ancillary studies
Sponsors
National Cancer Institute (NCI)
M.D. Anderson Cancer Center
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
MALE
Healthy volunteers
No
Inclusion criteria
* All diagnosed patients with a primary penile malignancy, including those with squamous carcinoma
Exclusion criteria
* No patient meeting the above criteria will be excluded
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Prospectively collect data on the presenting features, management and outcome of penile carcinoma | Up to 15 years | Descriptive statistics will be utilized where applicable to address questions relevant to the study aims. |
Countries
United States
Outcome results
None listed